Advertisements

Ketoconazol Bexal

Quick links to important sections

Ketoconazol Bexal

Advertisements

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Ketoconazol Bexal

Property Description
Active ingredient Ketoconazole
Form Topical Shampoo, Cream, or Gel
Pharmacological class Azole Antimycotic
General purpose Controlling fungal/yeast overgrowth on skin/scalp
Origin Synthetic imidazole derivative

1. Ketoconazol Bexal: A Synthetic Antifungal Agent

Ketoconazol Bexal is a medicinal preparation for topical application containing the active ingredient Ketoconazole, which is classified as an Azole Antimycotic agent. Ketoconazole is a synthetic imidazole derivative designed to address conditions caused by fungal or yeast overgrowth. This compound belongs to the category of antifungals intended for dermatological use. This single-ingredient product is clinically recognized for its fungistatic efficacy against a broad range of dermatophytes and yeasts.

2. Composition, Delivery Form, and General Purpose

The medication is commonly available in topical dosage form(s), such as a Topical Shampoo, Cream, or Gel, designed for application directly to the affected dermal area. These formulations utilize an aqueous or emollient base to ensure the necessary concentration of Ketoconazole is delivered efficiently to the skin surface via the topical route of administration. Azole antifungals are recognized for being effective in treating superficial fungal infections due to their focused effectiveness. This preparation is often positioned for patients seeking control over persistent, visible fungal manifestations on the skin or scalp.

3. High-Level Action: Disruption of Fungal Growth

Ketoconazole performs its primary function by disrupting the structural integrity of the fungal cell membrane, which is vital for the organism's survival. The compound achieves this by inhibiting the synthesis of ergosterol, a key sterol component required to build and maintain the fungal cell wall. By blocking the necessary pathway for ergosterol production, the medication prevents the fungal cells from maturing and proliferating, which exerts a fungistatic activity that halts the progression of the localized infection.

Advertisements

What side effects are possible with Ketoconazol Bexal?

Possible Side Effects and Safety Information

The safety profile of oral Ketoconazol Bexal is structured around specific risks, primarily severe liver injury (hepatotoxicity), adrenal gland problems (adrenal insufficiency), and serious cardiovascular effects.

Clinically Significant Adverse Reactions

The most serious risk documented in official regulatory sources is potentially fatal hepatotoxicity. This has led to mandated requirements for monitoring liver function tests (LFTs), including AST, ALT, ALP, and bilirubin, at baseline and regularly throughout treatment. Failure to monitor LFTs or the presence of acute/chronic hepatic impairment are specific contraindications.

Adrenal insufficiency is another key risk, requiring close observation and monitoring of adrenal function.

Serious cardiovascular effects, including QT prolongation and the risk of Torsade de Pointes (a potentially fatal irregular heart rhythm), are documented, making the drug contraindicated in patients with pre-existing QTc prolongation.

Common Side Effects

Commonly documented adverse reactions in patients treated for specific conditions, such as Cushing's syndrome, include increased liver enzymes, nausea, vomiting, abdominal pain, diarrhea, pruritus (itching), and rash.

Safety Restrictions and Contraindications

Safety documents impose numerous restrictions. The drug is contraindicated for use in:

  • Patients with acute or chronic liver disease.
  • Pregnant or breastfeeding women.
  • Patients with QTc prolongation.
  • Patients taking specific concomitant medicines that can cause serious drug-drug interactions, particularly those that prolong the QT interval or increase the systemic exposure of the co-administered drug to dangerous levels.
Advertisements

Overdose and Emergency Response

Overdose information for topical Ketoconazole formulations is defined by official regulatory bodies through two primary exposure scenarios. Excessive application of the cream, gel, or shampoo on the skin is documented to cause localized, transient skin reactions. These manifestations often include erythema (redness), swelling, and a burning sensation at the site of application, and are generally expected to resolve once the product is discontinued. This localized reaction does not typically warrant emergency intervention.

The more serious exposure scenario is the accidental oral ingestion of the topical product. If accidental swallowing occurs, it is required that a healthcare provider or a Poison Control Center be contacted immediately. Immediate medical help must be sought if signs of severe systemic reaction or complications arise. These include any symptoms of collapse, seizure, or difficulty breathing, which necessitate a call to emergency services. In the event of ingestion, management must be symptomatic and supportive, as no specific antidote is available. Furthermore, official guidance for the management of certain liquid topical products, such as shampoo, explicitly cautions against inducing vomiting or performing gastric lavage due to the potential risk of aspiration.

Advertisements

Therapeutic Uses of Ketoconazol Bexal

Key Uses and Benefits of Ketoconazol Bexal

Ketoconazol Bexal is commonly used in situations involving symptoms related to physical discomfort of skin conditions, and is relevant in contexts marked by increased discomfort or tension. Topical forms of this medication are applied across domains where additional symptomatic support is needed.

It is applied in addressing symptom clusters that may become intense or disruptive, contributes to easing the overall symptom load and supports patients during episodes of heightened discomfort.


Used in Areas Where Symptomatic Support is Needed

Ketoconazol Bexal is relevant when symptoms intensify and supportive relief is needed, and is applicable in conditions marked by increased physiological stress. It is commonly used to help with symptoms that interfere with daily comfort, and is relevant in clinical settings marked by heightened patient distress.

Quick Fact: Support for Stability

The medication helps address groups of symptoms that may appear suddenly or fluctuate, and may assist with maintaining functional stability. This provides support that helps ease the overall symptom burden.


Applied Across Domains Where Symptomatic Support is Needed

Commonly used across conditions involving episodic or fluctuating manifestations. It provides supportive relief when symptoms interfere with routine activities, contributing to easing the overall symptom load and where short-term symptomatic assistance is needed.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

The eligibility for using Ketoconazol Bexal (topical formulations) is defined by official regulatory documentation, focusing on absolute contraindications and specific population restrictions.


Contraindicated Populations

The product is absolutely contraindicated in patients who have a known hypersensitivity or allergy to ketoconazole or to any other ingredients (excipients) in the specific formulation, as stated in regulatory labels.


Age-Related Eligibility

Safety and effectiveness of the topical cream, gel, or shampoo have not been established in children under the age of 12 years. Use in adults and adolescents aged 12 and older is generally permitted under labeled conditions, but the minimum age can vary by specific formulation.


Physiological Restrictions

For pregnancy, the medicine is assigned to US FDA Pregnancy Category C, meaning it should only be used if the potential benefit justifies the potential risk to the fetus. Caution is advised for nursing women, as it is not known whether the drug is excreted in human milk after topical administration. Due to minimal systemic absorption, official labels typically do not impose restrictions based on hepatic or renal impairment for the topical formulations. The product is not for ophthalmic (eye) use and should be applied cautiously to a scalp that is broken or inflamed.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The use of Ketoconazol Bexal with many other medicines is restricted or prohibited due to its powerful effect as an inhibitor of the CYP3A4 enzyme and its ability to affect the heart's electrical activity (QT prolongation). These interactions can significantly raise the concentration of co-administered medicines in the blood, leading to severe adverse reactions or a heightened risk of serious heart rhythm abnormalities.

Key restrictions involve:

  • Contraindicated Combinations: Co-administration is strictly avoided with medicines like simvastatin and lovastatin (due to risk of severe muscle damage), and drugs that prolong the QT interval (e.g., quinidine, pimozide), which can lead to life-threatening heart rhythm issues. Sedative medicines such as oral midazolam and triazolam are also contraindicated due to the risk of prolonged and intensified sedative effects.
  • Acid-Reducing Agents: Medicines that decrease stomach acid, such as antacids and Proton Pump Inhibitors, can significantly reduce Ketoconazole's absorption, making it less effective. Administration with antacids must be separated by at least 1-2 hours.
  • CYP3A4 Inducers: Medicines that increase the activity of the CYP3A4 enzyme, such as rifampin, should generally be avoided as they may lower Ketoconazole levels, potentially leading to treatment failure.

Patients should inform their healthcare provider of all prescription drugs, over-the-counter medicines, and supplements currently being taken to properly manage or avoid these documented interactions.

Advertisements

Mechanism of Action

Enzyme Inhibition: Blocking Fungal Sterol Production

Ketoconazole functions as an inhibitor of lanosterol 14alpha-demethylase ( CYP51A1), an enzyme in the fungal metabolic pathway responsible for sterol synthesis. This action specifically prevents the synthesis of ergosterol, the sterol required for maintaining the structure of the fungal cell membrane. The drug achieves this interaction by binding to the heme iron of the CYP51A1 enzyme.

Cellular Disruption and Fungistatic Activity

The resulting lack of ergosterol and the concurrent buildup of toxic, dysfunctional sterol precursors compromise the fungal cell membrane's integrity and function. This dual disruption leads to increased membrane permeability and impaired transport systems. This specific cellular damage imposes a fungistatic effect, which translates to halting the organism's ability to grow, replicate, and expand its population.

Advertisements

Dosage and Administration Information

How to Use Ketoconazol Bexal: Official Administration Guidelines

Ketoconazol Bexal, in its prescription-strength 2% formulations (Cream, Gel, and Shampoo), is administered solely via the topical route of administration. The medicine is strictly designated for external use and must not be used orally, ophthalmically, or intravaginally.


Dosing and Frequency Patterns

The required quantity for application is the amount necessary to cover the entire affected area and the immediate surrounding skin surface. Treatment is structured around short, defined courses that vary by formulation and application site.

  • Once Daily: This frequency is typically used for the Cream formulation in treating infections such as Tinea Versicolor and Cutaneous Candidiasis.
  • Twice Daily: The Cream is commonly applied at this frequency for conditions like Seborrheic Dermatitis.
  • Twice Weekly or Intermittent: The 2% Shampoo for Seborrheic Dermatitis is officially applied twice weekly for the treatment phase, or intermittently (e.g., once every 1–2 weeks) for prophylaxis.

Duration of use is limited to specific cycles, ranging from 2 weeks for Tinea Versicolor, up to 4 weeks for Seborrheic Dermatitis, and extending to 6 weeks for Tinea Pedis, depending on the site of application.


Procedural and Age-Specific Rules

When using the 2% Shampoo, a specific administration instruction requires the lather to remain in contact with the skin for a period of 5 minutes before being thoroughly rinsed off with water.

For most prescription 2% formulations, the safety and effectiveness have not been established for use in pediatric patients under 12 years of age. Use in children is specified for those 12 years of age and older.

Advertisements

Recent Clinical Evidence

Ketoconazol Bexal: Recent Clinical Evidence


Evidence for Seborrhoeic Dermatitis, Dandruff, and Pityriasis Versicolor

The evidence base for topical Ketoconazole, including the formulations used in Ketoconazol Bexal, primarily consists of clinical research for conditions linked to yeast overgrowth on the skin and scalp. Randomized Controlled Trials (RCTs), often conducted using a double-blind method, form the core of the evidence. These studies were applied in research contexts involving fluctuating or unstable symptoms, with researchers tracking patterns in symptoms over defined time intervals.

Studies monitored outcomes related to physical discomfort and linked to inflammatory or irritative states. The primary measures included formal assessments of Clinical Cure/Success and Mycological Cure. Findings describe patterns observed in the studies, reporting the evolution of symptoms in the observed populations. Research also examined trials that followed patients to observe how symptoms change over time, including research tracking patterns of recurrence of the condition.


Evidence for Other Superficial Fungal Infections

Research has also examined the use of Ketoconazol formulations for other conditions associated with acute or disruptive episodes, such as common fungal skin infections (e.g., Tinea Cruris, Tinea Pedis). The evidence for these indications was studied for earlier phase Clinical Trials that supported the initial regulatory approval of the medication. These studies explored short-term symptom changes, mainly focusing on whether a patient achieved Clinical Clearance and Mycological Eradication.


Known Research Gaps and Uncertainties

Research highlights what is known — and what is still uncertain — about the evidence base. For some indications, the evidence quality varies across studies, and the follow-up durations were limited to the short-term. There is limited information for long-term outcomes that track patient status beyond the intermediate prophylactic follow-up periods. Comparative evidence is limited for certain formulations against other available treatment options. Research limitation frames include the observation that study results reflect the specific conditions under which they were conducted, and findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Ketoconazole Topical: MedlinePlus Drug Information (NIH)
  2. Label: KETOCONAZOLE cream (DailyMed - U.S. National Library of Medicine)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Ketoconazol Bexal (FAQ)


Q: Is Ketoconazol Bexal considered an antifungal or an anti-inflammatory medicine?

Ketoconazol Bexal is primarily classified by regulatory agencies as an Azole Antimycotic (an antifungal agent) because its main function is to halt fungal growth. Official product information for the topical cream notes that it can act rapidly on symptoms such as pruritus (itching), which is commonly associated with inflammation caused by the infection.


Q: How quickly does Ketoconazol Bexal usually start to relieve symptoms like itching?

Regulatory documents indicate that the topical medicine often acts rapidly on pruritus (itching), meaning users may observe a reduction in itching before the visible signs of the infection itself begin to clear. Observing the full recommended treatment duration is typically necessary to help eradicate the underlying fungal infection.


Q: Does Ketoconazol Bexal work for all types of fungal skin infections?

According to official indications, Ketoconazol Bexal is approved to treat infections caused by specific types of organisms, including dermatophytes (such as Tinea) and certain yeasts (such as Malassezia species). It is not intended for all types of fungal or bacterial skin conditions. Determining if this medicine is appropriate for a specific diagnosis typically requires consulting a healthcare provider.


Q: Is it normal to feel a mild burning or stinging sensation when first applying the cream/shampoo?

Yes, regulatory documents list skin burning sensation as a commonly reported adverse reaction that occurs at the application site. Other common local reactions include application site pruritus (itching) and erythema (redness).


Q: Can using Ketoconazol Bexal shampoo cause hair dryness or a change in hair texture?

Official information derived from studies and post-marketing surveillance reports abnormal hair texture, including mild dryness of the scalp, as potential side effects associated with the shampoo formulation.


Q: Is it possible for Ketoconazol Bexal to cause a rash or increased redness where it is applied?

Yes, according to official adverse event reports, application site erythema (redness) is commonly reported after use. Less frequently, patients have reported rash and contact dermatitis (an irritation or allergic reaction on the skin) after applying the product.


Q: Why is Ketoconazol Bexal not recommended for use on broken or severely irritated skin?

Official labeling advises users to apply the topical medicine cautiously, especially if the scalp or skin is inflamed or broken. The labeling advises caution, as applying the product to damaged skin may be associated with increased local irritation or altered absorption.


Q: Does Ketoconazol Bexal interact with any common over-the-counter skin products like moisturizers?

Formal interaction studies are often focused on systemic medicines. However, official regulatory instructions recommend separating the application of this medicine from certain other topical treatments, such as corticosteroids, to avoid a sudden rebound of the underlying condition.


Q: How long after symptoms clear up should I continue using Ketoconazol Bexal?

Official regulatory instructions advise that, to help fully clear the infection and prevent the condition from immediately returning, treatment should generally be continued until a few days after all signs and symptoms have completely disappeared.


Q: If the infection returns after treatment, can Ketoconazol Bexal be used again?

Yes, official regulatory documents state that the shampoo formulation is recommended for both the initial clearing of conditions like seborrheic dermatitis and for intermittent prophylaxis. This means the shampoo can be used occasionally (e.g., every one to two weeks) to manage and prevent recurrence.


Q: Can Ketoconazol Bexal be used for conditions other than skin fungus and dandruff?

Yes, the product is formally approved for the topical treatment of other conditions related to fungal or yeast overgrowth. This includes certain types of tinea (ringworm) infections, such as Tinea Corporis (ringworm of the body) and Tinea Cruris (jock itch), as well as Cutaneous Candidiasis.


Q: Does sun exposure or tanning need to be avoided while using Ketoconazol Bexal?

Photosensitivity (increased skin sensitivity to sunlight) is not a common side effect of the cream or standard shampoo. However, for some formulations, regulatory information notes that protective measures, such as using sunscreen or wearing protective clothing, are suggested during use.


Q: Can Ketoconazol Bexal shampoo remove curl from permed or chemically treated hair?

Yes, according to post-marketing reports compiled by regulatory agencies, an adverse reaction known as 'removal of curl from permanently waved hair' has been reported with the use of the shampoo formulation.


Q: What should I do if I accidentally get the shampoo or cream in my eyes or mouth?

If the cream or shampoo accidentally gets into the eyes, official instructions advise that they should be bathed gently with cold water. In the event of accidental ingestion of the product, official guidance recommends seeking supportive and symptomatic measures.


Q: Can Ketoconazol Bexal be used to treat athlete's foot or jock itch?

Yes, the cream formulation is indicated in official regulatory documents for the treatment of both Tinea Cruris (commonly known as jock itch) and Tinea Pedis (commonly known as athlete's foot), which are both types of dermatophyte infections.


Q: What kind of severe allergic reactions should a user be aware of when using this medication?

Severe allergic reactions are potential side effects. Post-marketing reports compiled in regulatory documents list severe reactions such as hypersensitivity and angioedema. Angioedema involves swelling of the face, tongue, or throat and may be accompanied by difficulty breathing.


Q: Why do people sometimes experience hair loss as a reported side effect of ketoconazole shampoo?

Regulatory documents list alopecia (hair loss) as an undesirable effect that has been reported in post-marketing surveillance for the shampoo formulation. This means it is a known possible side effect.

Advertisements

How should Ketoconazol Bexal be stored and disposed of?

Official Storage and Disposal Requirements

The storage and disposal instructions for Ketoconazol Bexal (topical ketoconazole) are strictly governed by regulatory labeling to maintain product stability and ensure safety.

Storage Requirement Official Condition (Regulatory Labeling)
Temperature Store below 25 C or 30 C; Do not freeze or refrigerate.
Protection Protect from light; Keep container tightly closed.
Child Safety Keep out of the sight and reach of children and pets.
Disposal Dispose of unused product or waste material in accordance with local requirements.

The medicine must be kept in its original container and protected from extreme temperatures, including freezing. Due to the toxicity of the active ingredient to aquatic life, official disposal protocols require avoiding environmental release to water or sewers. All storage conditions are intended to ensure the stability of the medicine until the expiration date.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ketoconazol Bexal found in:

A-Z Index: